# Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

> **NCT01627145** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Overactive Bladder Syndrome

## Interventions

- **DRUG:** Solifenacin

## Key facts

- **NCT ID:** NCT01627145
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2012-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01627145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01627145, "Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01627145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*